Publications for Graham Johnston

2021 href="http://dx.doi.org/10.1016/j.phrs.2017.09.021">[More van Nieuwenhuijzen, P., Parker, K., Liao, V., Houlton, J., Kim, Information] H., Johnston, G., Hanrahan, J., Collins, M., Clarkson, A. (2021). Targeting GABAC Receptors Improves Post-Stroke 2017 Motor Recovery. Brain Sciences, 11(3), 315( 1-19). [More views of an expert witness. Australian Journal of Forensic Information] Sciences, 49(6), 626-636. [Mor e Information] Hinton, T., Johnston, G. (2020). GABA-enriched teas as neuro- Ng, C., Duke, R., Hinton, T., Johnston, G. (2017). Effects of nutraceuticals. Neurochemistry International, 141, 104895. href="http://dx.doi.org/10.1016/j.neuint.2020.104895">[More modulation by structurally diverse positive modulators. Information] European Journal of Pharmacology, 806, 83-90. [More (2020). The origins and early history of neurochemistry and its Information] societies. Journal of Neurochemistry, 152(1), 8-28. href="http://dx.doi.org/10.1111/jnc.14839">[More Actions on Receptors for the Inhibitory Neurotransmitter Information] GABA. In Goncalo C Justino (Eds.), : From Beart, P., Hinton, T., Johnston, G. (2020). Yoga and GABA: Biosynthesis to Human Health, (pp. 335-350). Rijeka: InTech. New Insights from the Science. Journal of Yoga, Physical [More Therapy and Rehabilitation, 2(4), 1-3. Information] 2019 Johnston, G. (2017). GABA Australis, some reflections on the history of GABA receptor research in Australia. Hinton, T., Jelinek, H., Viengkhou, V., Johnston, G., Matthews, Pharmacological Research, 116, 32-38. [More Stress in a University Student Cohort. Frontiers in Nutrition, 6, Information] 1-8. [More (2017). GABA-(rho) receptors: distinctive functions and Information] molecular pharmacology. British Journal of Pharmacology, Solomon, V., Tallapragada, V., Chebib, M., Johnston, G., 174(13), 1881-1894. [More of recent developments in non- modulators. Information] European Journal of Medicinal Chemistry, 171, 434-461. [More Australasian Society of Clinical and Experimental Information] Pharmacologists in the 1980s. Pharmacological Research, 116, Devenish, S., Johnston, G., Chebib, M., Hanrahan, J. (2019). 3-6. [More adherent HEK293 cells. Protein Expression and Purification, Information] 154, 7-15. [More 2016 Information] Ng, C., Duke, R., Hinton, T., Johnston, G. (2016). GABAA 2018 receptor cysteinyl mutants and the ginkgo lactones bilobalide and . European Journal of Hinton, T., Johnston, G. (2018). Antagonists of Ionotropic Pharmacology, 777, 136-146. [More Therapeutic Indications. In Janko Samardzic (Eds.), GABA And Information] Glutamate - New Developments In Neurotransmission Johnston, G. (2016). Unsaturated Analogues of the Research, (pp. 91-105). Serbia: IntechOpen. [More Aminocrotonic and 4-Aminotetrolic Acids. Neurochemical Information] Research, 41(3), 476-480. [More Neurotransmitter in the Brain. Reference Module in Biomedical Information] Sciences. United States: Elsevier. [More Information] Abdelhalim, A., Karim, N., Chebib, M., Aburjai, T., Khan, I., Skilbeck, K., Johnston, G., Hinton, T. (2018). Long-lasting Johnston, G., Hanrahan, J. (2015). Antidepressant, Anxiolytic effects of early-life intervention in mice on adulthood and Antinociceptive Activities of behaviour, GABAA receptor subunit expression and synaptic Constituents from Rosmarinus Officinalis. Journal of Pharmacy clustering. Pharmacological Research, 128, 179-189. [More (GABAC) Selective Antagonists Derived from the Bioisosteric Information] Modification of 4-Aminocyclopent-1-enecarboxylic Acid: Amides and Hydroxamates. Journal of Medicinal Chemistry, Johnston, G. (2015). Flavonoid nutraceuticals and ionotropic 56(13), 5626-5630. [More Neurochemistry International, 89, 120-125. href="http://dx.doi.org/10.1016/j.neuint.2015.07.013">[More Information] 2012 Hanrahan, J., Chebib, M., Johnston, G. (2015). Interactions of Karim, N., Curmi, J., Gavande, N., Johnston, G., Hanrahan, J., flavonoids with ionotropic GABA receptors. Advances in Tierney, L., Chebib, M. (2012). 2'-Methoxy-6-methylflavone: Pharmacology, 72, 189-200. [More activating and modulating actions at GABA(A) receptors. Information] British Journal of Pharmacology, 165(4), 880-896. [More Information] Role(s) of GABAI Receptors in the Brain. Journal of Thompson, A., McGonigle, I., Duke, R., Johnston, G., Lummis, Neuroimmune Pharmacology, 10(3), 45-456. [More Ginkgo biloba extracts. The FASEB Journal, 26(5), 1884-1891. Information] [More 2014 Information] Yamamoto, I., Absalom, N., Carland, J., Doddareddy, M., Abdelhalim, A., Chebib, M., Aburjai, T., Johnston, G., Gavande, N., Johnston, G., Hanrahan, J., Chebib, M. (2012). Hanrahan, J. (2014). GABAA Receptor Modulation by Differentiating Enantioselective Actions of GABOB: A Compounds Isolated from Salvia triloba L. Advances in Possible Role for 244 in the Binding Site of GABAC Biological Chemistry, 4(2), 148-159. [More href="http://dx.doi.org/10.1021/cn3000229">[More Information] Information] Blednov, Y., Benavidez, J., Black, M., Leiter, C., Osterndoff- Fernandez, S., Karim, N., Mewett, K., Chebib, M., Johnston, Kahanek, E., Johnson, D., Borghese, C., Hanrahan, J., Johnston, G., Hanrahan, J. (2012). Flavan-3-ol esters: new agents for G., Chebib, M., et al (2014). GABAA Receptors Containing p1 exploring modulatory sites on GABAA receptors. British Subunits Contribute to In Vivo Effects of Ethanol in Mice. PloS Journal of Pharmacology, 165(4), 965-977. [More 5381.2011.01615.x">[More Information] Information] Karim, N., Wellendorph, P., Absalom, N., Bang, L., Jensen, M., Hall, B., Karim, N., Chebib, M., Johnston, G., Hanrahan, J. Hansen, M., Lee, H., Johnston, G., Hanrahan, J., Chebib, M. (2014). Modulation of Ionotropic GABA Receptors by 6- (2012). Low nanomolar GABA effects at extrasynaptic Methoxyflavanone and 6-Methoxyflavone. Neurochemical a4b1/b3d GABAA receptor subtypes indicate a different Research, 39, 1068-1078. [More Pharmacology, 84(4), 549-557. href="http://dx.doi.org/10.1016/j.bcp.2012.05.017">[More Johnston, G. (2014). as an Ionotropic GABA Information] Receptor Agonist. Neurochemical Research, 39(10), 1942- Huang, S., Lewis, T., Lummis, S., Thompson, A., Chebib, M., 1947. [More Information] ginkgolides at recombinant human r1 GABAc receptors. Neuropharmacology, 63(6), 1127-1139. [M Johnston, G. (2013). Advantages of an antagonist: ore Information] and other GABA antagonists. British Journal of Pharmacology, Yamamoto, I., Carland, J., Locock, K., Gavande, N., Absalom, 169(2), 328-336. [More Structurally Diverse GABA Antagonists Interact Differently Information] with Open and Closed Conformational States of the p1 Gavande, N., Kim, H., Doddareddy, M., Johnston, G., Chebib, Receptor. ACS Chemical Neuroscience, 3(4), 293-301. [More pharmacological evaluation of fluorescent and biotinylated Information] antagonists of P1 GABA(c) receptors. ACS Medicinal Chemistry Letters, 4(4), 402-407. [More Karim, N., Gavande, N., Wellendorph, P., Johnston, G., Information] Hanrahan, J., Chebib, M. (2011). 3-Hydroxy-2'-methoxy-6- Karim, N., Wellendorph, P., Absalom, N., Johnston, G., methylflavone: A potent anxiolytic with a unique selectivity Hanrahan, J., Chebib, M. (2013). Potency of gaba at human profile at GABBA receptor subtypes. Biochemical recombinant gaba alpha receptors expressed in xenopus Pharmacology, 82(12), 1971-1983. [More href="http://dx.doi.org/10.1007/s00726-012-1456-y">[More Information] Information] Yamamoto, I., Deniau, G., Gavande, N., Chebib, M., Johnston, Locock, K., Yamamoto, I., Tran, P., Hanrahan, J., Chebib, M., G., O'Hagan, D. (2011). Agonist responses of (R)- and (S)-3- Johnston, G., Allan, R. (2013). γ-Aminobutyric Acid(C) fluoro-??-aminobutyric acids suggest an enantiomeric fold for GABA binding to GABA(C) receptors. Chemical Information] Communications, 47(28), 7956-7958. [More Mewett, K., Allan, R., Duke, R., Johnston, G., Hanrahan, J. Information] (2009). Guanidino Acids Act as p1 GABAc Receptor Hanrahan, J., Chebib, M., Johnston, G. (2011). Flavonoid Antagonists. Neurochemical Research, 34(10), 1704-1711. [More Pharmacology, 163(2), 234-245. href="http://dx.doi.org/10.1111/j.1476- Chebib, M., Hanrahan, J., Johnston, G. (2009). Neurologically- 5381.2011.01228.x">[More Information] active Compounds (II). Patent No. 2002364767. Thompson, A., Jarvis, G., Duke, R., Johnston, G., Lummis, S. Hanrahan, J., Johnston, G., Kumar, R., Chebib, M. (2009). (2011). B and bilobalide block the pore of the 5- Neurologically-active Compounds (III). Patent No. 1773740. HT3 receptor at a location that overlaps the binding site. Neuropharmacology, 60, 488-495. [M Matos, S., Kim, H., Abdel-Halim, H., Kumar, R., Johnston, G., ore Information] Hanrahan, J. (2009). Novel, potent and selective GABAC antagonists inhibit myopia development and facilitate learning Gavande, N., Karim, N., Johnston, G., Hanrahan, J., Chebib, M. and memory. Journal of Pharmacology and Experimental (2011). Identification of Benzopyran-4-one Derivatives Therapeutics, 328(2), 448-457. [More ChemMedChem: chemistry enabling drug discovery, 6(8), 1340- Information] 1346. [More Mewett, K., Fernandez, S., Pasricha, A., Pong, A., Devenish, S., Information] Hibbs, D., Chebib, M., Johnston, G., Hanrahan, J. (2009). Synthesis and biological evaluation of flavan-3-ol derivatives as Ng, C., Kim, H., Gavande, N., Yamamoto, I., Kumar, R., positive modulators of GABAA receptors. Bioorganic and Mewett, K., Johnston, G., Hanrahan, J., Chebib, M. (2011). Medicinal Chemistry, 17(20), 7156-7173. [More Chemistry, 3(2), 197-209. href="http://dx.doi.org/10.4155/FMC.10.286">[More Information] Hanrahan, J., Johnston, G. (2009). Synthesis of -Aminobutyric Acid Analogs. In Hughes, A.B. (Eds.), Amino Acids, Peptides Yow, T., Pera, E., Absalom, N., Heblinski, M., Johnston, G., and Proteins in Organic Chemistry Volume 1 Origins and Hanrahan, J., Chebib, M. (2011). Naringin directly activates Synthesis of Amino Acids, (pp. 573-689). Weinheim, Germany: inwardly rectifying Wiley - V C H Verlag GmbH & Co. KGaA. [More Q. British Journal of Pharmacology, 163(5), 1017-1033. href="http://dx.doi.org/10.1111/j.1476- 5381.2011.01315.x">[More Information] Fernandez, S., Nguyen, M., Yow, T., Chu, C., Johnston, G., Hanrahan, J., Chebib, M. (2009). The flavonoid glycosides, Gavande, N., Yamamoto, I., Salam, N., Tu-Hoa, A., Burden, P., myricitrin, gossypin and naringin exert anxiolytic action in Johnston, G., Hanrahan, J., Chebib, M. (2011). Novel Cyclic mice. Neurochemical Research, 34(10), 1867-1875. [More Synthesis, and Pharmacology. ACS Medicinal Chemistry Information] Letters, 2(1), 11-16. [More Information] 2008 Abdel-Halim, H., Hanrahan, J., Hibbs, D., Johnston, G., 2010 Chebib, M. (2008). A molecular basis for agonist and antagonist actions at GABA(C) receptors. Chemical Biology Gavande, N., Johnston, G., Hanrahan, J., Chebib, M. (2010). and Drug Design (Print), 71(4), 306-327. (SR- 0285.2008.00642.x">[More Information] 95531). Organic and Biomolecular Chemistry, 8(18), 4131- 4136. [More Hinton, T., Chebib, M., Johnston, G. (2008). Enantioselective Information] actions of 4-amino-3-hydroxybutanoic acid and (3-amino-2- hydroxypropyl)methylphosphinic acid at recombinant Johnston, G., Chebib, M., Hanrahan, J., Mewett, K. (2010). GABA(C) receptors. Bioorganic and Medicinal Chemistry Neurochemicals for the Investigation of GABAc Receptors. Letters, 18(1), 402-404. [More href="http://dx.doi.org/10.1007/s11064-010-0271-7">[More Information] Information] Fernandez, S., Mewett, K., Hanrahan, J., Chebib, M., Johnston, Skilbeck, K., Johnston, G., Hinton, T. (2010). Stress and G. (2008). Flavan-3-ol derivatives are positive modulators of GABA(A) Receptors. Journal of Neurochemistry, 112(5), 1115- GABA(A) receptors with higher efficacy for the alpha(2) 1130. [More Information] 55(5), 900-907. [M ore Information] Locock, K., Johnston, G., Allan, R. (2009). GABA Analogues Kumar, R., Chebib, M., Hibbs, D., Kim, H., Johnston, G., Derived from 4-Aminocyclopent-1-enecarboxylic Acid. Salam, N., Hanrahan, J. (2008). Novel gamma-aminobutyric Neurochemical Research, 34(10), 1698-1703. [More activity and structure-activity relationships. Journal of Medicinal Chemistry, 51(13), 3825-3840. [More rho(1) GABA(C) receptor. Neuroscience, 137(2), 607-617. href="http://dx.doi.org/10.1016/j.neuroscience.2005.08.071">[ More Information] Carland, J., Johnston, G., Chebib, M. (2008). Relative impact of residues at the intracellular and extracellular ends of the human Johnston, G., Hanrahan, J., Chebib, M., Duke, R., Mewett, K. GABA(C) rho1 receptor M2 domain on picrotoxinin activity. (2006). Modulation of Ionotropic GABA Receptors by Natural European Journal of Pharmacology, 580(1), 27-35. [More 316). United States: Academic Press. href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retri eve&db=pubmed&dopt=Abstract&list_uids=17175819">[More Skilbeck, K., Hinton, T., Johnston, G. (2008). Sex-differences Information] and stress: effects on regional high and low affinity [3H]GABA binding. Neurochemistry International, 52(6), 1212-1219. [More (2006). Modulation of ionotropic GABA receptors by natural Information] products of plant origin. Advances in Pharmacology, 54, 285- 316. [More Information] in schizophrenia. Cell Science Reviews, 5, 180-194. 2007 2005 Granger, R., Campbell, E., Johnston, G. (2005). (+)- And (-)- Chebib, M., Hanrahan, J., Kumar, R., Mewett, K., Morriss, G., : efficacious positive modulators of GABA action at Wooller, S., Johnston, G. (2007). (3- human recombinant alpha1beta2gamma2L GABA(A) receptors. Aminocyclopentyl)methylphosphinic acids: Novel GABA(C) Biochemical Pharmacology, 69(7), 1101-1111. [More href="http://dx.doi.org/10.1016/j.neuropharm.2006.09.014">[M Information] ore Information] Hall, B., Chebib, M., Hanrahan, J., Johnston, G. (2005). 6- Skilbeck, K., O'Reilly, J., Johnston, G., Hinton, T. (2007). Methylflavanone, a more efficacious positive allosteric Antipsychotic drug administration differentially affects modulator of gamma-aminobutyric acid (GABA) action at [(3)H]muscimol and [(3)H] GABA(A) receptor human recombinant alpha2beta2gamma2L than at binding sites. Progress in Neuro-Psychopharmacology and alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors Biological Psychiatry, 32(2), 492-498. [More Pharmacology, 512(2-3), 97-104. href="http://dx.doi.org/10.1016/j.ejphar.2005.02.034">[More Skilbeck, K., O'Reilly, J., Johnston, G., Hinton, T. (2007). The Information] effects of antipsychotic drugs on GABAA receptor binding Johnston, G. (2005). GABA(A) receptor channel depend on period of drug treatment and binding site examined. pharmacology. Current Pharmaceutical Design, 11(15), 1867- Schizophrenia Research, 90(39508), 76-80. [More href="http://dx.doi.org/10.2174/1381612054021024">[More Information] Information] 2006 Chebib, M., Hanrahan, J., Johnston, G., Kumar, R. (2005). Patent No. 6962907. Skilbeck, K., O'Reilly, J., Johnston, G., Hinton, T. (2006). Antipsychotic drug effects on GABA(A) receptors. Schleimer, S., Johnston, G., Henderson, J. (2005). Novel oral Australasian Schizophrenia Conference 2006, United Kingdom: drug administration in an animal model of neuroleptic therapy. Taylor & Francis. Journal of Neuroscience Methods, 146(2), 159-164. [More Fernandez, S., Wasowski, C., Loscalzo, L., Granger, R., Information] Johnston, G., Paladini, A., Marder, M. (2006). Central nervous system depressant action of flavonoid glycosides. European Gibbs, M., Johnston, G. (2005). Opposing roles for GABAA Journal of Pharmacology, 539(3), 168-176. [More young chicks. Neuroscience, 131(3), 567-576. href="http://dx.doi.org/10.1016/j.neuroscience.2004.11.033">[ More Information] Hanrahan, J., Mewett, K., Chebib, M., Matos, S., Eliopoulos, C., Crean, C., Kumar, R., Burden, P., Johnston, G. (2006). 2004 Diastereoselective synthesis of (+/-)-(3- aminocyclopentane)alkylphosphinic acids, conformationally Carland, J., Moorhouse, A., Barry, P., Johnston, G., Chebib, M. restricted analogues of GABA. Organic and Biomolecular (2004). Charged Residues At The 2' Position Of Human Chemistry, 4(13), 2642-2649. [More Open State Probability. Journal of Biological Chemistry, Information] 279(52), 54153-54160. [More Crittenden, D., Park, A., Qiu, J., Silverman, R., Duke, R., Information] Johnston, G., Jordan, M., Chebib, M. (2006). Enantiomers of cis-constrained and flexible 2-substituted GABA analogues Hall, B., Chebib, M., Hanrahan, J., Johnston, G. (2004). exert opposite effects at recombinant GABA(C) receptors. -independent positive modulation of g-aminobutyric Bioorganic and Medicinal Chemistry, 14(2), 447-455. [More and a1h2 GABAA receptors. European Journal of Information] Pharmacology, 491(1), 1-8. [More Huang, S., Duke, R., Chebib, M., Sasaki, K., Wada, K., Information] Johnston, G., Chebib, M., Hanrahan, J., Mewett, K. (2003). GABAc receptors as drug targets. CNS and Neurological Schleimer, S., Hinton, T., Dixon, G., Johnston, G. (2004). Gaba Disorders, 2(4), 260-268. Transporters Gat-1 And Gat-3 In The Human Dorsolateral Prefrontal Cortex In Schizophrenia. Neuropsychobiology, 50(3), Krehan, D., Frølund, B., Krogsgaard-Larsen, P., Kehler, J., 226-230. [More seleninic acid bioisosteres of as novel and Information] selective GABAc receptor antagonists. Neurochemistry International, 42(7), 561-565. [More Information] Ginkgo Biloba, As Antagonists At Recombinant Alpha1Beta2Gamma2L Gabaa Receptors. European Journal of Hanrahan, J., Chebib, M., Davucheron, N., Hall, B., Johnston, Pharmacology, 494(2-3), 131-138. : a href="http://dx.doi.org/10.1016/j.ejphar.2004.04.051">[More negative modulator at gabaa receptors. Bioorganic and Information] Medicinal Chemistry Letters, 13(14), 2281-2284. [More Information] (2004). Ionotropic Gaba Receptors As Therapeutic Targets For Memory And Sleep Disorders. Annual Reports in Medicinal 2002 Chemistry, 39(1), 13-23. [More Information] Wada, K. (2002). Bilobalide, from Ginkgo biloba, and enhancement of wild type alpha-1 beta-2gamma-2l GABAa Carland, J., Moore, A., Hanrahan, J., Mewett, K., Duke, R., receptors by , pentobarbitone and a steroid. 3rd Johnston, G., Chebib, M. (2004). Mutations Of The 2' College of Health Sciences Research Conference, Sydney: In The M2 Domain Of The Human Gabac Rho1 Subunit Alter University of Sydney. Agonist Responses. Neuropharmacology, 46, 770-781. [M Huang, S., Duke, R., Chebib, M., Johnston, G., Sasaki, K., ore Information] Wada, K. (2002). Effects of bilobalide and the of Ginkgo bilobaon GABA-mediated currents modulated by Duke, R., Chebib, M., Hibbs, D., Mewett, K., Johnston, G. GABAa modulators. 20th International Australasian Winter (2004). Synthesis And Resolution Of 2-Methyl Analogues Of Conference on Brain Research. GABA. Tetrahedron-Asymmetry, 15(11), 1745-1751. [More Campbell, E., Chebib, M., Duke, R., Hall, B., Hanrahan, J., Information] Johnston, G., Mewett, K. (2002). Epigallocatechin gallate, from green tea, and related agents as modulators of human brain Campbell, E., Chebib, M., Johnston, G. (2004). The Dietary GABA receptors. 5th Australia/Japan Symposium on Drug Flavonoids And (-)-Epigallocatechin Gallate Enhance Design and Development. The Positive Modulation By Diazepam Of The Activation By GABA Of Recombinant GABA(A) Receptors. Biochemical Duke, R., Chebib, M., Duke, C., Johnston, G., Roufogalis, B. Pharmacology, 68(8), 1631-1638. [More Pharmacy, , 27-33. Information] Huang, S., Duke, R., Chebib, M., Johnston, G., Sasaki, K., Granger, R., Campbell, E., Johnston, G. (2004). Wada, K. (2002). Investigation of the effects of bilobalide from Monoterpenes Produce Unprecedented Enhancement Of GABA Ginkgo biloba on wild type alpha-5beta-2gamma-2l alpha- Action At GABA-A Receptors. Journal of Neurochemistry, 1beta-2gamma-2l and alpha-1beta-2 GABAa receptors. 88(S1), 79-79. Australian Health and Meldical Research Conference. 2003 Johnston, G. (2002). Medicinal chemistry and molecular pharmacology of GABAc receptors. Current Topics in Krehan, D., Frølund, B., Ebert, B., Nielsen, B., Krogsgaard- Medicinal Chemistry, 2(8), 903-913. [More related analogues of THIP as GABAc antagonists. Bioorganic Information] and Medicinal Chemistry, 11(23), 4891-4896. [More Rimoldi, J., Weimann, B. (2002). Natural and synthetic Information] substances related to human health. Pure and Applied Huang, S., Duke, R., Chebib, M., Sasaki, K., Wada, K., Chemistry, 74(10), 1957-1985. [More ginkgo biloba, is an antagonist at recombinant a1b2y2l GABAA Information] receptors. European Journal of Pharmacology, 464(1), 1-8. [More Information] MeTACA) and (+/-)-trans-2- Chebib, M., Duke, R., Duke, C., Connor, M., Mewett, K., aminomethylcyclopropanecarboxylic acid ((+/-)-TAMP) can Johnston, G. (2003). Convulsant actions of Calycanthine. differentiate rat rho3 from human rho1 and rho2 recombinant Toxicology and Applied Pharmacology, 190(1), 58-64. [More Information] href="http://dx.doi.org/10.1038/sj.bjp.0704432">[More Information] Johnston, G. (2003). Dietary chemicals and brain function. Journal and Proceedings of the Royal Society of New South Campbell, E., Duke, R., Johnston, G., Granger, R. (2002). Wales, 135, 57-71. Valerian and GABA receptors. Australian Health and Medical Research Congress. 2001 Hall, B., Hanrahan, J., Johnston, G., Hambley, T., Hibbs, D. (2001). 6-Methylflavone. Acta Crystallographica. Section E: Structure Reports Online, E57. Hanrahan, J., Mewett, K., Chebib, M., Burden, P., Johnston, G. (2001). An improved, versatile synthesis of the GABAc antagonists (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA) and (piperidin-4-yl)methylphosphinic acid (P4MPA). Royal Chemical Society. Journal. Perkin Transactions 1, 1, 2389-2392. [More Information] Farrar, N., Chambers, N., Carlsson, A., Denyer, G., Johnston, G. (2001). Effect of a series of novel sulphonylthioureas on glucose tolerance in the obese fa/fa Zucker rat. Clinical and Experimental Pharmacology and Physiology, 28, 386-391. [More Information] Chebib, M., Duke, R., Allan, R., Johnston, G. (2001). The effects of cyclopentane and cyclopentene analogues of GABA at recombinant GABAc receptors. European Journal of Pharmacology, 430, 185-192. [More Information]